KRAS and non-small cell lung carcinoma: Rekhtman et al., (2016) identified that 40% of these tumors are similar to SCLC which is characterized by p53 and RB1 gene alterations, whereas 55.5% had mutations such as STK11/Kras that are commonly seen in NSCLC.